Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
Author:
Affiliation:
1. Brain Tumor Laboratory, Roger Williams Medical Center, 825 Chalkstone Avenue, Prior 222, Providence, RI 02908, USA
2. Department of Neurological Surgery, Boston University School of Medicine, Boston, MA 02118, USA
Abstract
Publisher
Hindawi Limited
Subject
General Medicine,Immunology,Immunology and Allergy
Link
http://downloads.hindawi.com/journals/jir/2012/831090.pdf
Reference83 articles.
1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2. Brain Tumors
3. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
4. Recent developments on immunotherapy for brain cancer
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A syngeneic spontaneous zebrafish model oftp53-deficient, EGFRviii, and PI3KCAH1047R-driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapsein vivo;2023-10-20
2. Drug resistance in glioblastoma: from chemo- to immunotherapy;Cancer Drug Resistance;2023-10-11
3. Enhancement of Microglia Functions by Developed Nano‐Immuno‐Synergist to Ameliorate Immunodeficiency for Malignant Glioma Treatment;Advanced Healthcare Materials;2023-09-12
4. New therapy for pancreatic cancer based on extracellular vesicles;Biomedicine & Pharmacotherapy;2023-06
5. Integrating machine learning and bioinformatics analysis to m6A regulator-mediated methylation modification models for predicting glioblastoma patients’ prognosis and immunotherapy response;Aging;2023-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3